longbridge

Bridgebio Pharma

BBIO
----

All Shareholders

Shareholder Type

  • Institutions85.79%
  • Hedge funds10.32%
  • Individuals & Insiders3.86%
  • State-owned enterprises0.04%

Major Shareholders

Major Shareholders Latest
Shareholder
Janus Henderson Group Ltd.
7.22%14.11M0.48%+931.27K
Farallon Capital Management, L.L.C.
5.50%10.74M0.71%+1.38M
BlackRock, Inc.
5.26%10.29M2.00%-3.92M
Viking Global Investors LP
5.01%9.79M0.09%-157.00K
Vanguard Capital Management, LLC
4.61%9.02M0.05%+81.33K
KKR & Co. Inc.
4.23%8.26M2.56%-5.00M
Vanguard Portfolio Management, LLC
3.92%7.66M0.21%-423.85K
Wellington Management Group LLP
2.72%5.31M1.45%+2.82M
Neil KumarCo-Founder, CEO & Director
2.59%5.06M0.01%-20.00K
Two Sigma Investments, LP
2.42%4.72M0.82%+1.60M
Aisling Capital Management LP
2.35%4.59M0.25%-500.00K
State Street Investment Management
2.27%4.44M0.25%-498.39K
Citadel Advisors LLC
1.92%3.76M0.30%+586.09K
D. E. Shaw & Co., L.P.
1.86%3.63M0.56%+1.09M
Invesco Ltd.
1.80%3.52M0.47%-916.23K
Geode Capital Management, LLC
1.75%3.42M0.76%-1.50M
Jane Street Group, LLC
1.50%2.93M0.60%+1.18M
Adage Capital Management, L.P.
1.15%2.25M0.85%+1.65M
UBS Asset Management AG
1.14%2.24M0.10%-192.86K
Franklin Templeton Inc.
1.10%2.16M0.20%+392.41K
© 2026 Longbridge｜Terms of ServicePrivacy Policy